Month: November 2011

Mergers & Acquisitions

Federated Municipal Closed-End Funds Announce Intention to Conduct Tender Offers for Preferred Shares

November 7, 2011 0

Federated Municipal Closed-End Funds Announce Intention to Conduct Tender Offers for Preferred Shares PR Newswire PITTSBURGH, Nov. 7, 2011 PITTSBURGH , Nov. 7, 2011 /PRNewswire/ — Federated Premier Municipal Income Fund (NYSE: FMN) and Federated Premier Intermediate Municipal Income Fund (NYSE: FPT) today announced that the Board of Trustees of each fund has authorized its respective fund to conduct a voluntary tender offer for up to 100% of the fund’s outstanding auction market preferred shares (AMPS) […]

Stock Analysts

Cosan to Buyback 2.6M Stock (ADM) (CZZ)

November 7, 2011 0

Brazilian sugar and ethanol producer, Cosan Limited ( CZZ ) recently received its Board of Directors’ approval for the renewal of its share buyback program. Pursuant to the approval, Cosan can buyback roughly 2.6 million shares (or 0.6% of the company’s outstanding shares) to be held in treasury for future sale or cancellation. The buyback program remains valid till November 3, 2012 […]

Stock Analysts

Target Date Set for Vivus Drug (VVUS)

November 7, 2011 0

Vivus Inc. ( VVUS ) recently announced the acceptance of the company’s new drug application (NDA) for Qnexa by the US Food and Drug Administration (FDA) for review. The regulatory body has set a target date of April 17, 2012 for the application […]

Fast Money Episodes

Markets Into Year-End

November 7, 2011 0

[cnbc 3000055389] Can investors still make money in this market? Discussing how investors should position their portfolios in the midst of market uncertainty? Jason Trennert, Strategas Research Partners, weighs in. […]

Fast Money Episodes

The Mill

November 7, 2011 0

[cnbc 3000055927] The Fast Money traders break down stories they’re hearing in the market, and figure out if it’s fact or fiction, and how to play it. […]

Stock Analysts

Impella Pumps Up Abiomed (ABMD) (THOR)

November 7, 2011 0

Leading cardiac assist devices maker Abiomed ’s ( ABMD ) second-quarter fiscal 2012 adjusted (excluding one-time items other than stock-based compensation expenses) earnings per share of 3 cents outperformed the Zacks Consensus Estimate of a loss of 8 cents as the company saw robust sales for its popular Impella cardiac pumps. On a reported basis, Abiomed turned in a profit in the quarter riding on record sales. […]

Stock Analysts

Earnings Scorecard: Aimco (EQR)

November 7, 2011 0

Apartment Investment and Management Company ( AIV ), popularly known as Aimco, reported third quarter 2011 funds from operations (FFO) of $43.6 million or 36 cents per share compared with $48.9 million or 42 cents per share in the year-ago period. Funds from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income. […]

Stock Analysts

MDT Begins CoreValve Trial in Japan (BSX) (EW) (MDT)

November 7, 2011 0

Leading medical devices player, Medtronic ( MDT ) has begun a clinical trial of its CoreValve system in Japan. The system provides a treatment option for patients with symptomatic, severe aortic stenosis who are at high risk, or are ineligible, for open-heart surgery. The CoreValve system has been implanted in patients in more than 50 countries outside the US since it received CE Mark approval in March 2007. […]